TrialMicrobiology spectrum2026

Preclinical and clinical evaluation of vancomycin plus delpazolid combination therapy for MRSA bacteremia: a multicenter, double-blinded, randomized, parallel design, phase IIa clinical trial.

Kyung-Hwa Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.